Earnings History Data for Takeda Pharmaceutical Company Limited (TAK) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.

Takeda Pharmaceutical Company Limited

Takeda Pharmaceutical Company Limited operates as a research-based pharmaceutical company, engaged in manufacturing, marketing, and importing/exporting pharmaceutical drugs. Takeda's core business comprise of ethical drugs and its portfolio includes lansoprazole for the treatment of peptic ulcers, leuprolide acetate for the treatment of prostate cancer and endometriosis, pioglitazone hydrocholoride for the treatment of diabetes, and candesartan cilexetil for the treatment of hypertension. The Company promotes enhancing R&D pipeline, while concentrating its management resources to the four core therapeutic areas: lifestyle-related diseases, oncology and urological diseases, central nervous system disease and gastroenterological diseases. It operates in two segments- Ethical drug business and Consumer healthcare business. Consumer healthcare business provides Alinamin (vitamin B1 derivative preparations, etc.), Benza (cold remedies). Takeda Pharmaceutical Company Limited is headquartered in Osaka, J...
Release Date Time Est. Time Symbol Name Market Cap (M) Rep. EPS Est. EPS Last years EPS SeekingAlpha Headline Price Change Ext. Hours Price Ext. Hours Change 52 Week Range Volume Avg. Volume Ext. Hours Volume Top Mover
01-02-2024 PM TAK Takeda Pharmaceutical Company Limited 46,340 0.51 0.00 0.46 Takeda Pharmaceutical GAAP EPS of ¥94.00, revenue of ¥3212.9B; reaffirms FY23 guidance
[2/1/2024 1:21 AM]		 14.39 -0.21 
(-1.44%)		 14.67 0.07 
(0.48%)		 13.19 - 17.15 3,286,572 1,660,000 9,696
26-10-2023 PM TAK Takeda Pharmaceutical Company Limited 45,210 0.50 0.00 0.52 13.39 -1.11 
(-7.62%)		 13.88 -0.62 
(-4.28%)		 12.89 - 17.15 8,415,719 1,500,000 16,133
11-05-2023 PM TAK Takeda Pharmaceutical Company Limited 53,150 0.39 0.00 0.38 Takeda Pharmaceutical Non-GAAP EPS of ¥558.00, revenue of ¥4.03B; initiates FY23 guidance
[5/11/2023 3:31 AM]		 16.16 -0.82 
(-4.80%)		 16.64 -0.34 
(-2.00%)		 12.28 - 17.15 5,513,151 1,950,000 6,766
28-07-2022 PM TAK Takeda Pharmaceutical Company Limited 45,370 0.56 0.00 0.51 Takeda Pharmaceutical Non-GAAP EPS of ¥145.00, revenue of ¥972.5B, maintains FY guidance
[7/28/2022 2:14 AM]		 14.81 0.13 
(0.85%)		 14.71 0.02 
(0.14%)		 13.05 - 17.31 2,211,701 3,030,000 22,259
11-05-2022 PM TAK Takeda Pharmaceutical Company Limited 45,400 0.38 0.00 0.41 Takeda Pharmaceutical GAAP EPS of ¥425.00, revenue of ¥3.42T
[5/11/2022 2:26 AM]		 13.95 -0.57 
(-3.93%)		 14.11 -0.41 
(-2.82%)		 13.17 - 17.56 2,213,744 2,560,000 2,643
28-10-2021 PM TAK Takeda Pharmaceutical Company Limited 43,460 0.45 0.00 0.47 14.11 0.29 
(2.10%)		 14.15 0.33 
(2.39%)		 13.80 - 19.96 4,258,324 2,190,000 59,601
31-07-2020 PM TAK Takeda Pharmaceutical Company Limited 56,950 0.57 0.00 0.56 Takeda Pharmaceutical misses on revenue
[7/31/2020 4:28 AM]		 18.16 0.0 
(-0.01%)		 18.42 0.26 
(1.43%)		 12.43 - 20.92 425,349 1,162,062 7,344